A 'distributed degron' allows regulated entry into the ER degradation pathway.
Protein degradation is employed in both regulation and quality control. Regulated degradation of specific proteins is often mediated by discrete regions of primary sequence known as degrons, whereas protein quality control involves recognition of structural features common to damaged or misfolded proteins, rather than specific features of an individual protein. The yeast HMG-CoA reductase isozyme Hmg2p undergoes stringently regulated degradation by machinery that is also required for ER quality control. The 523 residue N-terminal transmembrane domain of Hmg2p is necessary and sufficient for regulated degradation. To understand how Hmg2p undergoes regulated degradation by the ER quality control pathway, we analyzed over 300 mutants of Hmg2p. Regulated degradation of Hmg2p requires information distributed over the entire transmembrane domain. Accordingly, we refer to this determinant as a 'distributed' degron, which has functional aspects consistent with both regulation and quality control. The Hmg2p degron functions in the specific, regulated degradation of Hmg2p and can impart regulated degradation to fusion proteins. However, its recognition is based on dispersed structural features rather than primary sequence motifs. This mode of targeting has important consequences both for the prediction of degradation substrates and as a potential therapeutic strategy for targeted protein degradation using endogenous degradation pathways.
Gardner
R G
RG
Department of Biology, University of California San Diego, 9500 Gilman Drive, La Jolla, CA 92093, USA.
Hampton
R Y
RY
D000595:Amino Acid Sequence; D019086:Bridged Bicyclo Compounds, Heterocyclic / Q000494:pharmacology; D004721:Endoplasmic Reticulum / Q000378:metabolism*; D004795:Enzyme Stability; D049452:Green Fluorescent Proteins; D006903:Hydroxymethylglutaryl CoA Reductases / Q000737:chemistry / Q000235:genetics*; D025782:Hydroxymethylglutaryl-CoA-Reductases, NADP-dependent; D008148:Lovastatin / Q000494:pharmacology; D008164:Luminescent Proteins; D008239:Lysine / Q000235:genetics; D008565:Membrane Proteins / Q000737:chemistry / Q000235:genetics; D008969:Molecular Sequence Data; D009154:Mutation; D017510:Protein Folding; D017433:Protein Structure, Secondary; D011993:Recombinant Fusion Proteins / Q000378:metabolism; D014233:Tricarboxylic Acids / Q000494:pharmacology; D014452:Ubiquitins / Q000378:metabolism; D015003:Yeasts
D019086:Bridged Bicyclo Compounds, Heterocyclic; D008164:Luminescent Proteins; D008565:Membrane Proteins; D011993:Recombinant Fusion Proteins; D014233:Tricarboxylic Acids; D014452:Ubiquitins; C075117:squalestatin 1; D049452:Green Fluorescent Proteins; D008148:Lovastatin; D006903:Hydroxymethylglutaryl CoA Reductases; D025782:Hydroxymethylglutaryl-CoA-Reductases, NADP-dependent; D008239:Lysine